GMED - GenoMed Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GMED - GenoMed Inc.

GMED 83.90

+36.0%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jmhollen who wrote (82)	1/24/2004 8:37:19 PM
From: Gary Mohilner	Read Replies (2) of 347

Thanks John, It would be nice if we could attract some other people over here to add to your efforts. You speak as though you've had a personal interest in the company, have you. If I understand what they're currently doing, it's employing currently available drugs, like ACE inhibitors, in ways that are dramatically different from what they were intended for. I gather they've got patents pending for these applications and that many patients who've been treated have had tremendous improvements. As I see it, the problem is probably convincing the FDA, as they like trials that cost hundreds of millions and involve thousands of patients. The good news is that if the results GMED produces don't get the FDA's attention, they should get the attention of the developers of the drugs that GMED's using. With patents covering their use, GMED should profit nicely from partnerships intended to expand their usage by the manufacturers if they cannot convince the FDA by themselves. Do I get the picture correctly. I've only been looking at it for a short time. I'm sure there's much to learn about what they're doing, but from what I've seen already they impressed me. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next